首页 正文

Management of dyslipidaemia in patients with comorbidities - facing the challenge: Heart failure

{{output}}
The combined prevalence of heart failure (HF) with coronary atherosclerosis is frequent and often causally linked. The aim of this review is to elucidate whether lipid lowering drugs (LLDs) are useful in this context. The role of LLDs is interesting in two way... ...